{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1382262945501497609.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"David Marin"}],"foaf:familyName":[{"@value":"Marin"}],"foaf:givenName":[{"@value":"David"}]}],"career":[{"institution":{"notation":[{"@value":"From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1362262945501497728","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1056/nejmoa1910607"},{"@type":"URI","@value":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1910607"}],"notation":[{"@value":"Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1056/nejmoa1910607_UiEK4ayU5zEYRdvb1ybwPbCZ3lX"}]}